Cervical cancer incidence can increase despite HPV vaccination

Slides:



Advertisements
Similar presentations
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 353, Issue 9155, Pages (March 1999)
Pathogenesis of urinary tract infections with normal female anatomy
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies  Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.
ZIKA App – A great resource from the World Health Organization (WHO)
Malaria receptivity in the tsunami-hit coastal villages of southern India  K Gunasekaran, P Jambulingam, R Srinivasan, C Sadanandane, PS Boopathy Doss,
Pharmacogenetics and future drug development and delivery
Thank God for Richard Dawkins?
The benefits and harms of breast cancer screening
Distinctly different purpura on different arms
Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study  Alejandra Castanon, MD, Rebecca Landy, PhD,
The Lancet Public Health
Brian J Coburn, David J Gerberry, Sally Blower 
Lei Gao, Qi Jin  The Lancet Infectious Diseases 
Author gender in The Lancet journals
Controlling Ebola: key role of Ebola treatment centres
Infections related to totally implantable venous-access ports
Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus  T. Bärnighausen, D.E. Bloom, E.T. Cafiero,
Underestimate of annual malaria imports to Canada – Author reply
Klebsiella pneumoniae liver abscesses
When less is more: how many doses of PCV are enough?
Changing trends of neglected tropical diseases in China
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Constantly high incidence of scarlet fever in Germany
Effective cross-sector collaborations create sustainability
Can famine relief meet health and hunger goals simultaneously?
A next-generation Alzheimer's centre for Madrid
Until eradication, awareness
Disease and stigma The Lancet Volume 354, (December 1999)
Emerging resistant clone of Mycobacterium tuberculosis in west Asia
Glenn E Talboy, Kamani Lankachandra, Diane M Harper 
Arnaud Chiolero  The Lancet Public Health 
HIV myths should not be resuscitated
Challenges to eliminate rabies virus infection in China by 2020
Michael J Goldacre, Jenny J Maisonneuve  The Lancet 
Modelling the effect of early detection of Ebola
Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study  Helen C Johnson, MSc, Erin I Lafferty, PhD, Rosalind.
Assessment of herd immunity from human papillomavirus vaccination
What would happen if we stopped vaccination?
Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?  Stefanie Desmet, Jan Verhaegen, Marc Van Ranst,
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Errata The Lancet Infectious Diseases
Telling it like it isn't: truth and lies in a post-9/11 world
Cervical cancer: lessons learned from neglected tropical diseases
Thank God for Richard Dawkins?
Low-technology approaches
Diagnosis of tuberculous meningitis with invasive pulmonary sampling
ACST: which subgroups will benefit most from carotid endarterectomy?
Urine-Based HPV Testing as a Method to Screen for Cervical Cancer
Procalcitonin as a diagnostic marker for sepsis
Costs of eliminating HIV in South Africa have been underestimated
Steven A Narod  The Lancet  Volume 349, Issue 9068, (June 1997)
The 2009 influenza pandemic
GBD 2016 estimates problematic for South Africa
Infections related to totally implantable venous-access ports
Dengue pre-vaccination screening and positive predictive values
A remarkable report card on progress in COPD
Ebola control: rapid diagnostic testing
Volume 21, Issue 9, Pages (September 2014)
A 12 year outbreak of scarlet fever in Singapore
Chapter 78 Vaccination and Screening in Cervical Cancer
The dilemma of vaginal breech delivery worldwide
Chapter 77 Cervical Cancer: Burden of Disease
Volume 21, Issue 9, Pages (September 2014)
Symptom-based stratification of autoimmune diseases
Autism, maths, and sex: the special triangle
Volume 374, Issue 9694, Pages (September 2009)
A disease of the osteoblast
Presentation transcript:

Cervical cancer incidence can increase despite HPV vaccination Diane M Harper, Pekka Nieminen, Jorma Paavonen, Matti Lehtinen  The Lancet Infectious Diseases  Volume 10, Issue 9, Pages 594-595 (September 2010) DOI: 10.1016/S1473-3099(10)70182-1 Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 1 Sentinel warning By 2005, the incidence of cervical cancer had increased more than four times over the rate predicted by historical screening patterns for 30–39 year old Finnish women per 1 million person-years.7 The Lancet Infectious Diseases 2010 10, 594-595DOI: (10.1016/S1473-3099(10)70182-1) Copyright © 2010 Elsevier Ltd Terms and Conditions

Figure 2 Coverage of the 2003 Finnish cervical cancer screening programme in 2003 The dashed line represents the 70% minimum coverage rate that is needed to gain a population benefit from organised cervical cancer screening programmes.4,5 The Lancet Infectious Diseases 2010 10, 594-595DOI: (10.1016/S1473-3099(10)70182-1) Copyright © 2010 Elsevier Ltd Terms and Conditions